Genome editing allows for ‘faster, simpler’ CHO cell lines 03-Sep-2019 By Ben Hargreaves As MilliporeSigma expands its patent portfolio for its genome editing technology, the company’s head of strategy discusses how CRISPR is changing the bioproduction landscape.